Genomic Valley

News:

Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare | Metropolis Healthcare launches ‘Healthy Heart Meter’ campaign in honour of World Heart Day | String test may improve diagnosis, treatment of ulcers: Nobel laureate | Blood test could identify children at risk of obesity-related conditions, lipid analysis suggests | The Necessity of Comprehensive Flu Testing Packages to Minimise Repeated Examinations | Redcliffe Labs launch Gut Microbiome, HealthEx tests to promote preventive healthcare | Redcliffe Labs raises $42 million in Series C funding | Researchers find new diagnostic algorithm to differentiate between Alzheimer's disease, primary tauopathies | Strand Life Sciences launch Somatic Advantage 74 Liquid Biopsy (SA74 LB) Test | Molbio Diagnostics' Truenat System improving TB detection, treatment initiation in high-burden Nigeria | 1 in every 3 thyroid tests in Delhi NCR shows abnormal results | Nucleome Informatics launches gene test for detecting inherited retinal diseases | Redcliffe Labs achieves Six Sigma score or above | Eyeing Big Plans, Gene Sequencing leader Illumina adds India to its GCC network | Haematology lab with apheresis machine to come up in Uttarakhand | Redcliffe Labs launches test for Mpox | Cambrian Bioworks secures $1.45 million in seed funding | Metropolis healthcare launches two laboratories in Telangana | Diagnostics firm Labcorp weighs ramping up mpox testing capacity | Affordable TB testing technology developed by ICMR's regional centre | NCDRC directs Johnson & Johnson to pay Rs 35 lakh for faulty hip replacement device | Stryker Launches Next-Gen Surgical Camera in India, Enhancing Visualization Across Specialties | Amid mpox outbreak South Korea's PCR system markets to grow at 5% till 2033: GlobalData | IRGMA welcomes CDSCO's new guidelines, urges stringent measures to curb substandard gloves import | FDA recall orders for McGrath Mac’s Medtronic laryngoscope may hurt device sales: GlobalData | Artificial heart maker Carmat's shares slide on $11.5 mln capital hike | Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant | Expanding radiotherapy access, a critical solution to India's rising cancer burden | Polymed lines up ₹750 crore for expansion, buys over two years | Accuray introduces Helix system to help transform cancer treatment in India | Abbott follows rival Dexcom with OTC glucose monitor launch in US | Oxymed launches P2 Portable Oxygen Concentrator for Indian market | Wearable devices could help detect early signs of COVID-19, heart conditions, study suggests | Medical Device Park in Himachal to provide 10,000 jobs, says industries minister | Himachal Pradesh to return Centre's Rs 30 cr for medical device park | India to offer 20% capital subsidy for domestic production of medtech components | IASST develops new smart sensor for adjusting drug dosage to manage Parkinson’s Disease | Japanese delegation visits AIIMS Delhi to collaborate on National Centre for Medical Device Development, Validation and Skill Training | Dexcom announces launch of over-the-counter continuous glucose monitor | US FDA approves Abbott's aspirin free regimen for patients with HeartMate 3 heart pump

Genomic Valley

News:

Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare | Metropolis Healthcare launches ‘Healthy Heart Meter’ campaign in honour of World Heart Day | String test may improve diagnosis, treatment of ulcers: Nobel laureate | Blood test could identify children at risk of obesity-related conditions, lipid analysis suggests | The Necessity of Comprehensive Flu Testing Packages to Minimise Repeated Examinations | Redcliffe Labs launch Gut Microbiome, HealthEx tests to promote preventive healthcare | Redcliffe Labs raises $42 million in Series C funding | Researchers find new diagnostic algorithm to differentiate between Alzheimer's disease, primary tauopathies | Strand Life Sciences launch Somatic Advantage 74 Liquid Biopsy (SA74 LB) Test | Molbio Diagnostics' Truenat System improving TB detection, treatment initiation in high-burden Nigeria | 1 in every 3 thyroid tests in Delhi NCR shows abnormal results | Nucleome Informatics launches gene test for detecting inherited retinal diseases | Redcliffe Labs achieves Six Sigma score or above | Eyeing Big Plans, Gene Sequencing leader Illumina adds India to its GCC network | Haematology lab with apheresis machine to come up in Uttarakhand | Redcliffe Labs launches test for Mpox | Cambrian Bioworks secures $1.45 million in seed funding | Metropolis healthcare launches two laboratories in Telangana | Diagnostics firm Labcorp weighs ramping up mpox testing capacity | Affordable TB testing technology developed by ICMR's regional centre | NCDRC directs Johnson & Johnson to pay Rs 35 lakh for faulty hip replacement device | Stryker Launches Next-Gen Surgical Camera in India, Enhancing Visualization Across Specialties | Amid mpox outbreak South Korea's PCR system markets to grow at 5% till 2033: GlobalData | IRGMA welcomes CDSCO's new guidelines, urges stringent measures to curb substandard gloves import | FDA recall orders for McGrath Mac’s Medtronic laryngoscope may hurt device sales: GlobalData | Artificial heart maker Carmat's shares slide on $11.5 mln capital hike | Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant | Expanding radiotherapy access, a critical solution to India's rising cancer burden | Polymed lines up ₹750 crore for expansion, buys over two years | Accuray introduces Helix system to help transform cancer treatment in India | Abbott follows rival Dexcom with OTC glucose monitor launch in US | Oxymed launches P2 Portable Oxygen Concentrator for Indian market | Wearable devices could help detect early signs of COVID-19, heart conditions, study suggests | Medical Device Park in Himachal to provide 10,000 jobs, says industries minister | Himachal Pradesh to return Centre's Rs 30 cr for medical device park | India to offer 20% capital subsidy for domestic production of medtech components | IASST develops new smart sensor for adjusting drug dosage to manage Parkinson’s Disease | Japanese delegation visits AIIMS Delhi to collaborate on National Centre for Medical Device Development, Validation and Skill Training | Dexcom announces launch of over-the-counter continuous glucose monitor | US FDA approves Abbott's aspirin free regimen for patients with HeartMate 3 heart pump

ABOUT US

Who we are

Taking Care of Your Tomorrow

Welcome to Genomic Valley Biotech Limited, where innovation meets expertise to revolutionize healthcare. With a dedicated team boasting over 10 years of experience in Next-Generation Sequencing (NGS), oncology, and Artificial Intelligence (AI), we are at the forefront of integrating advanced technologies into biotechnology and healthcare solutions. Our team comprises highly skilled professionals passionate about utilizing their extensive knowledge to drive forward the fields of oncology research and diagnostics. We are committed to implementing both novel and validated methods, ensuring the delivery of accurate and confident results in our pursuit of better healthcare outcomes.

Genomic Valley Biotech Limited

ABOUT US

Who we are

Taking Care of Your Tomorrow
Genomic Valley Biotech Limited

Welcome to Genomic Valley Biotech Limited, where innovation meets expertise to revolutionize healthcare. With a dedicated team boasting over 10 years of experience in Next-Generation Sequencing (NGS), oncology, and Artificial Intelligence (AI), we are at the forefront of integrating advanced technologies into biotechnology and healthcare solutions. Our team comprises highly skilled professionals passionate about utilizing their extensive knowledge to drive forward the fields of oncology research and diagnostics. We are committed to implementing both novel and validated methods, ensuring the delivery of accurate and confident results in our pursuit of better healthcare outcomes.

SERVICES

Empowering healthcare with NGS and AI

We offer advanced Diagnostic Services using Next-Generation Sequencing (NGS) and AI for precise genetic analysis and personalized oncology treatments. Our Research Services drive innovation in oncology through NGS and AI, enhancing diagnostic tools and therapeutic strategies.

Personalized Healthcare

Personalized healthcare at Genomic Valley Biotech Limited is centered on tailoring medical treatment to individual patients based on their unique genetic profiles.

Genetic Disease Predisposition

Our genetic disease predisposition services focus on identifying individuals' susceptibility to various hereditary conditions.

Community Health Support

Community health support at Genomic Valley Biotech Limited aims to improve public health outcomes through comprehensive genomic screening programs.

AI-Based Genome Healthcare

At Genomic Valley Biotech Limited , we are pioneering AI-based genome healthcare research to revolutionize the way genetic data is analyzed and interpreted.

Metagenomics and Healthcare

Our metagenomics research focuses on studying the collective genomes of microbial communities within the human body and their impact on health and disease.

Extramural Research Project

Our extramural research projects involve collaborating with external academic institutions, research organizations, and industry partners to advance genomic science.

SERVICES

Empowering healthcare with NGS and AI

We offer advanced Diagnostic Services using Next-Generation Sequencing (NGS) and AI for precise genetic analysis and personalized oncology treatments. Our Research Services drive innovation in oncology through NGS and AI, enhancing diagnostic tools and therapeutic strategies.

Personalized Healthcare

Personalized healthcare at Genomic Valley Biotech Limited is centered on tailoring medical treatment to individual patients based on their unique genetic profiles.

Genetic Disease Predisposition

Our genetic disease predisposition services focus on identifying individuals' susceptibility to various hereditary conditions.

Community Health Support

Community health support at Genomic Valley Biotech Limited aims to improve public health outcomes through comprehensive genomic screening programs.

AI-Based Genome Healthcare

At Genomic Valley Biotech Limited , we are pioneering AI-based genome healthcare research to revolutionize the way genetic data is analyzed and interpreted.

Metagenomics and Healthcare

Our metagenomics research focuses on studying the collective genomes of microbial communities within the human body and their impact on health and disease.

Extramural Research Project

Our extramural research projects involve collaborating with external academic institutions, research organizations, and industry partners to advance genomic science.

FAQ

Frequently Asked Questions

For any other questions, please feel free to contact us.

We specialize in Next-Generation Sequencing (NGS)-based molecular diagnostics, focusing on identifying genetic mutations and abnormalities with advanced AI integration. Our services enable early detection and personalized treatment plans, particularly in oncology.

Our personalized healthcare utilizes NGS and AI technologies to tailor medical treatments based on individual genetic profiles. This approach enhances therapy effectiveness, minimizes adverse effects, and ensures tailored care aligned with each patient's genetic makeup.

We offer genetic disease predisposition analysis using NGS to predict susceptibility to hereditary conditions along with pharmacogenomics for recommendation of patient-centred drugs. This service supports proactive healthcare measures and informed decision-making for patients and healthcare providers.

We envision to integrate AI into NGS to conduct population-wide genetic screening aimed at improving public health outcomes. Our initiatives will help identify prevalent health risks and design targeted community health programs for disease prevention and management.

We leverage over a decade of experience in NGS and AI to pioneer advancements in cancer research. Our focus includes uncovering novel biomarkers and genetic insights, collaborating with leading institutions to develop more effective diagnostic tools and therapeutic strategies.

TESTIMONIALS

What our users say

Here's what our clients around the internet are saying about us.

Amit

@DrAmit

Genomic Valley Biotech Limited will be a trailblazer in integrating Next-Generation Sequencing and AI into healthcare. Their expertise and commitment to innovation will be evident in the precision and reliability of their diagnostic services. As a healthcare provider, I will trust their data and solutions to enhance patient outcomes and support informed decision-making.

Mohit

@DrMohit

Genomic Valley Biotech Limited will be transformative. Their advanced AI-based genome healthcare research will provide us with invaluable insights into genetic patterns, driving innovation in our personalized medicine approaches. Their dedication to excellence and cutting-edge technology will be truly commendable.

Shikha

@DrShikha

The personalized healthcare services at Genomic Valley Biotech Limited will revolutionize our approach to patient care. By tailoring treatments based on unique genetic profiles, they will ensure our patients receive the most effective therapies with minimal adverse effects. Their expertise in NGS and AI will be unmatched, making them an invaluable partner in our healthcare journey.

TESTIMONIALS

What our users say

Here's what our clients around the internet are saying about us.

Amit

@DrAmit

Genomic Valley Biotech Limited will be a trailblazer in integrating Next-Generation Sequencing and AI into healthcare. Their expertise and commitment to innovation will be evident in the precision and reliability of their diagnostic services. As a healthcare provider, I will trust their data and solutions to enhance patient outcomes and support informed decision-making.

Mohit

@DrMohit

Genomic Valley Biotech Limited will be transformative. Their advanced AI-based genome healthcare research will provide us with invaluable insights into genetic patterns, driving innovation in our personalized medicine approaches. Their dedication to excellence and cutting-edge technology will be truly commendable.

Shikha

@DrShikha

The personalized healthcare services at Genomic Valley Biotech Limited will revolutionize our approach to patient care. By tailoring treatments based on unique genetic profiles, they will ensure our patients receive the most effective therapies with minimal adverse effects. Their expertise in NGS and AI will be unmatched, making them an invaluable partner in our healthcare journey.

GALLERY

A glimpse into our company

GALLERY

A glimpse into our company

CONTACT

Get in touch with us

Send us a message

Fill the form to contact us

Message

CONTACT

Get in touch with us

Send us a message

Fill the form to contact us

Message

Genomic Valley Biotech Limited

4 KM Stone, Berri Chhara Road, P.O. Tanda Heri, Tehsil Bahadurgarh, District Jhajjar, HARYANA, INDIA - 124 507

Email: info@genomicvalley.in

Phone: +91 98113 41542